Pulmonx Corporation LUNG

Set alert

Price alert · LUNG

All alert types
2.58 USD -0.42 -14.14%

At close · Nov 2

2.50 -0.08 -3.10%

After hours · Nov 2, 4:00 PM ET

Bid
2.56 × 2
Ask
2.58 × 3
2.50 Day range 3.13
1.13 52-week range 3.25
YTD
+16.74%
1 year
+29.00%
Open
3.04
Prev close
3.01
Mkt cap
108.97M
Vol
1.44M
Avg vol
630.17K
EPS
-1.01
P/E
0.00
Div yield
0.00%
More statistics
Low
2.50
High
3.13
Forward P/E
-3.91
Beta
0.68
Short ratio
3.62
Inst. own
94.86%
Dividend
0.00
Ex-div date
Earnings
Jul 31, 2024
50-d avg
6.51
200-d avg
7.33
1y target
11.92

1D chart

Chart tools
Interval

Signals (49)
NameTimeAgo
MACD: Buy Signal4:00 PM13 hours ago
SMA: Bearish3:54 PM13 hours ago
SMA: Bearish3:54 PM13 hours ago
MACD: Sell Signal3:54 PM13 hours ago
MACD: Buy Signal3:53 PM13 hours ago
MACD: Sell Signal3:50 PM13 hours ago
SMA: Bullish3:46 PM13 hours ago
SMA: Bullish3:46 PM13 hours ago
MACD: Buy Signal3:46 PM13 hours ago
MACD: Sell Signal3:43 PM13 hours ago
MACD: Buy Signal3:37 PM13 hours ago
RSI: Oversold3:32 PM13 hours ago
MACD: Sell Signal3:29 PM13 hours ago
SMA: Bearish3:26 PM13 hours ago
SMA: Bearish3:26 PM13 hours ago
MACD: Buy Signal2:47 PM14 hours ago
RSI: Oversold2:43 PM14 hours ago
MACD: Sell Signal2:34 PM14 hours ago
RSI: Oversold2:23 PM14 hours ago
MACD: Buy Signal2:13 PM14 hours ago

Newest 20 of 49.

Analyst view

Consensus: buy

Buy
Price target (mean) 11.92 +361.9% upside
Target (low)
7.50
Target (mean)
11.92
Target (high)
16.00
Ratings (0m) 6 4 buy · 2 hold · 0 sell
  • Strong buy1
  • Buy3
  • Hold2
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 6
  • 1 month ago 6
  • 2 months ago 6

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

LUNG analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.44894-0.47 – -0.41-0.36-24.7%22.29M+15.6%5
Next quarter-0.39623-0.45 – -0.35-0.36-10.1%22.23M+17.9%5
Current year-1.56-1.58 – -1.52-1.60+2.5%82.32M+19.9%5
Next year-1.58-1.81 – -1.43-1.56-1.3%97.72M+18.7%5

Upgrades and downgrades

The latest rating changes

LUNG analyst upgrades and downgrades
DateFirmActionFromTo
Dec 11, 2024Wells FargoMaintainedEqual-WeightEqual-Weight
Dec 11, 2024CitigroupDowngradeBuyNeutral
Oct 31, 2024StifelMaintainedBuyBuy
Aug 1, 2024Piper SandlerMaintainedOverweightOverweight
Aug 1, 2024Canaccord GenuityMaintainedBuyBuy
Aug 1, 2024Wells FargoMaintainedEqual-WeightEqual-Weight
Jun 4, 2024Lake StreetInitiated—Buy
May 2, 2024Canaccord GenuityMaintainedBuyBuy
Apr 3, 2024Piper SandlerReiteratedOverweightOverweight
Feb 23, 2024CitigroupMaintainedBuyBuy
Feb 23, 2024Wells FargoDowngradeOverweightEqual-Weight
Feb 22, 2024StifelMaintainedBuyBuy
Feb 22, 2024Piper SandlerMaintainedOverweightOverweight
Feb 22, 2024Wells FargoMaintainedOverweightOverweight
Oct 31, 2023Piper SandlerMaintainedOverweightOverweight
Oct 31, 2023Canaccord GenuityMaintainedBuyBuy
Sep 5, 2023Craig-HallumInitiated—Buy
Aug 3, 2023Piper SandlerMaintainedOverweightOverweight
Jul 11, 2023CitigroupMaintainedBuyBuy
May 3, 2023CitigroupMaintained—Buy
May 3, 2023Piper SandlerMaintained—Overweight
May 3, 2023Morgan StanleyMaintained—Equal-Weight
Apr 3, 2023CitigroupMaintained—Buy
Feb 27, 2023Wells FargoUpgradeEqual-WeightOverweight
Feb 24, 2023CitigroupMaintained—Buy
Feb 23, 2023Canaccord GenuityMaintained—Buy
Feb 23, 2023Morgan StanleyMaintained—Equal-Weight
Jan 6, 2023Morgan StanleyMaintained—Equal-Weight
Jan 3, 2023B of A SecuritiesDowngradeNeutralUnderperform
Dec 12, 2022Wells FargoMaintained—Equal-Weight